Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Ali_Health
|
| gptkbp:acquisition |
multiple biotech firms
|
| gptkbp:ceo |
gptkb:Yuan_Li
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:employees |
over 10,000
|
| gptkbp:founded |
gptkb:1997
|
| gptkbp:headquarters |
gptkb:Hong_Kong
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sino Biopharmaceutical
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:market |
gptkb:Asia
gptkb:China global |
| gptkbp:partnerships |
various international pharmaceutical companies
|
| gptkbp:products |
vaccines
biopharmaceuticals diagnostics |
| gptkbp:research_focus |
oncology
cardiovascular diseases infectious diseases |
| gptkbp:revenue |
over HKD 10 billion
|
| gptkbp:stock_exchange |
gptkb:Hong_Kong_Stock_Exchange
|
| gptkbp:subsidiary |
Sino Biopharm (Guangdong) Co., Ltd.
Sino Biopharm (Shenzhen) Co., Ltd. |
| gptkbp:symbol |
1177. HK
|